Latitude Programming System
FDA premarket approval P910077/S163 · decided 2018-01-07
Approval details
- PMA number
- P910077
- Supplement
- S163
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Latitude Programming System
- Generic name
- Implantable cardioverter defibrillator (non-CRT)
- Applicant
- Boston Scientific
- Date received
- 2017-10-20
- Decision date
- 2018-01-07
- Days to decision
- 79 days
- Decision code
- APPR
- Product code
- LWS
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- Approval for multiple software upgrades and updates for the Model 3300 Latitude Programming System.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.